ConvaTec is a global medical products and technologies company, offering products and services in the areas of wound and skin care; ostomy care; continence and critical care; and infusion devices. ConvaTec has over 8,000 employees, with eleven manufacturing sites in eight countries, and does business in more than 100 countries. The company has $1.7B in annual sales and is owned by Nordic Capital and Avista Capital Partners.History: 1978 – ConvaTec created as a division of E.R. Squibb & Sons, Inc. 2008 – ConvaTec acquired by Nordic Capital and Avista Capital Partners2008 – ConvaTec acquires Unomedical2012 – ConvaTec acquires 180 Medical↑ 1.0 1.1 1.2 Wikipedia.
ConvaTec | Date: 2015-04-24
Ostomy appliances with a filter system that is resistant to clogging by waste expelled by the stoma are provided for waste management.
ConvaTec | Date: 2016-12-07
An antiseptic composition suitable for use on skin and wounds comprising a source of an antimicrobial agent and an agent which disrupts biofilms. More, particularly the invention relates to a composition capable of providing effective antimicrobial activity while at the same time avoiding wound and skin irritation and retardation of wound healing.
ConvaTec | Date: 2016-11-16
A stand-alone system for assessing wound exudates from the wound of a patient is described. The system contains functionality to detect, process and report various wound parameters. The system also may make treatment determinations based on these findings. The system may detect one or more physiological values of the wound exudates from the wound of the patient. The system may also compare detected physiological values to predetermined physiological values, in order to obtain a comparison result in real time. The system may include a processor (15) which provides an electronic signal based on the comparison result in which the electronic signal may corresponds to guidelines for treating the wound (3). The system described may be an accessory, which may be used on its own, or in conjunction with other wound treatment devices (9).
Agency: Cordis | Branch: FP7 | Program: CP-TP | Phase: NMP.2013.4.0-3 | Award Amount: 6.15M | Year: 2014
Early detection of an incipient wound infection is a challenge for the attending physician , since its early diagnosis allows the timely initiation of treatment, thus reducing the severity of the disease . Currently, however, wound infection is not diagnosed until becoming already evident. As a consequence, the treatment of the patient is further complicated and more likely to have a negative outcome4. Often wounds are treated with antibiotics before even the infection appears, leading to overdoses and development of bacterial resistance to antibiotics. Considering that optimal efficiency is reached when a material serves multiple functions without compromise, consortium partners have discovered the means to convert wound dressings into a diagnostic tool capable to inform both patient and therapist about the wound status, thus directing towards the following therapeutic step. The proposed functional materials include a real time diagnostic reaction that positively influences the wound healing due to the timely intervention to treat infection or proteolytic stasis in the wound The novel InFact technology will be translated into a low-cost, real-time diagnostic tool as a constituent part of a wound dressing material, i.e. the triple-P materials concept: - Protective - by a decoy substrate for destructive proteases - Predictive providing a cumulative wound status signal to predict the infection transition - Proactive - changing the dressing according to a signal, rather than on a schedule base, will provide therapeutic response in time, and not too late. More specifically, the functional materials (e.g. absorbent fibres and hydrocolloid pads) will incorporate immobilized substrates for three enzymes: myeloperoxidase, lysozyme and elastase. Upon infection, these enzymatic activities are highly elevated in wound fluids, and can be detected by the color change of the functional materials, visible via a window in the dressing.
ConvaTec | Date: 2016-05-24
A wound dressing having anti-microbial activity comprises a first fibre capable of bonding with silver (1) cations. The wound dressing comprises a blend of the first fibre to which silver (1) cations are bonded and a second fibre which is substantially free from silver. The wound dressing comprises from 0.01 to 5.0 percent by weight of silver (1) cations, based on the weight of fibre.
ConvaTec | Date: 2016-05-05
The invention relates to a method for dissolving the components of gel forming materials suitable for use in wound care comprising the steps of admixing said components with an ionic liquid. The ionic liquid may be selected from the group of tertiary amine N-oxides, N,N-dimethyl formamide/nitrogen tetroxide mixtures, dimethyl sulphoxide/paraformaldehyde mixtures and solutions of limium chloride in N,N-dimethyl acetamide or N-methyl pyrrolidone.
ConvaTec | Date: 2016-10-07
A coupling assembly for fastening an adhesive wafer to an ostomy appliance device, the coupling assembly including a captive connection between the adhesive wafer and ostomy appliance that permits captive relative displacement between the entire adhesive wafer and the entrance aperture of the appliance, to facilitate access to the wafer from the non-body-contacting side. The coupling assembly further comprises a fixation coupling for fixing the adhesive wafer in the operative position.
ConvaTec | Date: 2016-05-18
A spring-loaded bag connector having a spring-loaded valve and a housing comprising a fluid inlet portion and a fluid outlet portion. The spring-loaded bag connector is configured to connect with a fluid collection bag to generate a self-closing collection bag. Additionally, the spring-loaded bag connector is configured to couple with a second coupling element, such as a coupling connector, to facilitate the drainage and collection of waste to a fluid collection bag. Uncoupling of the bag connector and the second coupling element results in minimal fluid contamination on the outer surfaces of the bag connector system. The bag connector systems provided herein are included in medical appliances for body waste management.
ConvaTec | Date: 2016-07-29
A rectal drainage appliance is disclosed comprising a tubular element having an inflatable balloon at a distal end for anchoring the appliance in the rectum. The appliance includes one or more of: (i) first and second auxiliary lumens communicating with the inflatable balloon to provide independent inflation and pressure monitoring paths coupled to the balloon; (ii) a pressure state indicator defined by a mechanical element configured to flip between first and second states or shapes responsive to sensed pressure; and (iii) a collapsible auxiliary lumen larger than the inflation lumen, and configured to permit admission of irrigation fluid. The pressure state indicator may also be used in intestinal drains.
ConvaTec | Date: 2016-10-05
A stoma closure that includes a conformable portion for conforming to an individuals stoma. The conformable portion includes a sack containing particles. The conformable portion may include a gel that may be loose or be at least partly contained in a sack. The conformable portion may include foam. The conformable portion may be configured to permit venting of flatus, while obstructing the passage of liquid/solid stool.